(Q37876566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21586489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Trends in annualized relapse rates in relapsing-remitting multiple sclerosis and consequences for clinical trial design (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21586489%20AND%20SRC:MED&resulttype=core&format=json

relapsing-remitting multiple sclerosis

1 February 2020

main subject

0 references

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21586489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Richard Nicholas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21586489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sebastian Straube

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21586489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Heinz Schmidli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21586489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Simon Schneider

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21586489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

17 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21586489%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21586489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21586489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21586489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

1211-1217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21586489%20AND%20SRC:MED&resulttype=core&format=json

Assessing changes in relapse rates in multiple sclerosis

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

Two-stage design of clinical trials involving recurrent events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

Blinded sample size reestimation with negative binomial counts in superiority and non-inferiority trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

Statistical methods for the analysis of relapse data in MS clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

Sample size recalculation in internal pilot study designs: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

Refinement of the Clinical Scenario Evaluation Framework for Assessment of Competing Development Strategies with an Application to Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406309

21 January 2018

Identifiers

DOI

10.1177/1352458511406309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21586489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference